Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study.

by Benjamin Mou, Chris J Beltran, Sean S Park, Kenneth R Olivier, Keith M Furutani
Published 2014-01-01

SUPR-3D: A randomized phase iii trial comparing simple unplanned palliative radiotherapy versus 3d conformal radiotherapy for patients with bone metastases: study protocol

by Robert Olson, Roel Schlijper, Nick Chng, Quinn Matthews, Marco Arimare, Lindsay Mathews, Fred Hsu, Tanya Berrang, Alexander Louie, Benjamin Mou, Boris Valev, Joanna Laba, David Palma, Devin Schellenberg, Shilo Lefresne
Published 2019-10-01

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

by Robert Olson, Mitchell Liu, Alanah Bergman, Sonya Lam, Fred Hsu, Benjamin Mou, Tanya Berrang, Ante Mestrovic, Nick Chng, Derek Hyde, Quinn Matthews, Chad Lund, Daniel Glick, Howard Pai, Parminder Basran, Hannah Carolan, Boris Valev, Shilo Lefresene, Scott Tyldesley, Devin Schellenberg
Published 2018-10-01

Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC

by Andrea L.H. Arnett, MD, PhD, Benjamin Mou, MD, Dawn Owen, MD, PhD, Sean S. Park, MD, PhD, Katy Nelson, RN, Christopher L. Hallemeier, MD, Terence Sio, MD, MS, Yolanda I. Garces, MD, Kenneth R. Olivier, MD, Kenneth W. Merrell, MD, MS
Published 2019-04-01

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

by Robert Olson, Lindsay Mathews, Mitchell Liu, Devin Schellenberg, Benjamin Mou, Tanya Berrang, Stephen Harrow, Rohann J. M. Correa, Vasudeva Bhat, Howard Pai, Islam Mohamed, Stacy Miller, Famke Schneiders, Joanna Laba, Derek Wilke, Sashendra Senthi, Alexander V. Louie, Anand Swaminath, Anthony Chalmers, Stewart Gaede, Andrew Warner, Tanja D. de Gruijl, Alison Allan, David A. Palma
Published 2020-05-01